These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31981687)
1. Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicin. Combrink M; Loots DT; du Preez I Toxicol Lett; 2020 Apr; 322():104-110. PubMed ID: 31981687 [TBL] [Abstract][Full Text] [Related]
2. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
3. Deleterious effects of 28-day oral co-administration of first-line anti-TB drugs on spleen, blood and bone marrow chromosomes in normal rat. Sharma R; Sharma VL Drug Chem Toxicol; 2017 Apr; 40(2):154-163. PubMed ID: 27250504 [TBL] [Abstract][Full Text] [Related]
4. Cellular toxicity of isoniazid together with rifampicin and the metabolites of isoniazid on QSG-7701 hepatocytes. Zhang ZH; Tang JH; Zhan ZL; Zhang XL; Wu HH; Hou YN Asian Pac J Trop Med; 2012 Apr; 5(4):306-9. PubMed ID: 22449523 [TBL] [Abstract][Full Text] [Related]
5. Bile acids, lipid and purine metabolism involved in hepatotoxicity of first-line anti-tuberculosis drugs. Liu L; Li X; Huang C; Bian Y; Liu X; Cao J; Qu W; Miao L Expert Opin Drug Metab Toxicol; 2020 Jun; 16(6):527-537. PubMed ID: 32436768 [TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
9. Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures. Shen C; Meng Q; Zhang G; Hu W Br J Pharmacol; 2008 Feb; 153(4):784-91. PubMed ID: 18071298 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
11. Subchronic toxicity of human immunodeficiency virus and tuberculosis combination therapies in B6C3F1 mice. Rao GN; Lindamood C; Heath JE; Farnell DR; Giles HD Toxicol Sci; 1998 Sep; 45(1):113-27. PubMed ID: 9848118 [TBL] [Abstract][Full Text] [Related]
12. [The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance]. Tan S; Ding X; Tan Y; Cai X; Li Y Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):915-8. PubMed ID: 25609129 [TBL] [Abstract][Full Text] [Related]
13. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity. Tostmann A; Boeree MJ; Peters WH; Roelofs HM; Aarnoutse RE; van der Ven AJ; Dekhuijzen PN Int J Antimicrob Agents; 2008 Jun; 31(6):577-80. PubMed ID: 18358703 [TBL] [Abstract][Full Text] [Related]
14. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination. Tasduq SA; Singh K; Satti NK; Gupta DK; Suri KA; Johri RK Hum Exp Toxicol; 2006 Mar; 25(3):111-8. PubMed ID: 16634329 [TBL] [Abstract][Full Text] [Related]
16. First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform. Cao J; Mi Y; Shi C; Bian Y; Huang C; Ye Z; Liu L; Miao L Biochem Biophys Res Commun; 2018 Mar; 497(2):485-491. PubMed ID: 29454961 [TBL] [Abstract][Full Text] [Related]
17. Effect of cimetidine on hepatotoxicity induced by isoniazid-rifampicin combination in rabbits. Kalra BS; Aggarwal S; Khurana N; Gupta U Indian J Gastroenterol; 2007; 26(1):18-21. PubMed ID: 17401229 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin. Mathivha KT; Velaphi S Paediatr Int Child Health; 2017 May; 37(2):129-134. PubMed ID: 27455907 [TBL] [Abstract][Full Text] [Related]
19. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Sharma SK; Sharma A; Kadhiravan T; Tharyan P Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581 [TBL] [Abstract][Full Text] [Related]
20. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice. Vilchèze C; Kim J; Jacobs WR Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]